research

Studies on the tumor-suppressing activity of bevacizumab, a monoclonal antibody against human vascular endothelial growth factor

Abstract

Thesis (Ph. D. in Science)--University of Tsukuba, (A), no. 5716, 2011.3.25Includes bibliographical references (leaves 31-37

    Similar works